MedPath

Multidisciplinary Intervention for Mild Cognitive Impairment

Not Applicable
Conditions
Mild Cognitive Impairment
Registration Number
NCT02943187
Lead Sponsor
Gibson Institute of Cognitive Research
Brief Summary

The purpose of this investigation is to conduct a series of case studies on the impact of a novel functional medicine approach to improving cognitive skills, brain structure, and daily functioning for participants with Mild Cognitive Impairment (MCI).

Detailed Description

Using a multiple baseline design across cases with start point randomization, the proposed study will examine the outcomes from a combination of optimized diet, exercise, nutritional supplements, and cognitive training across domains on standardized measures used to monitor treatment effectiveness for Mild Cognitive Impairment (MCI).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Age 50+ previously diagnosed with MCI
  • Living in the greater Colorado Springs area
Exclusion Criteria
  • No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evidence of overall cognitive function improvementwithin 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Dementia Rating Scale (DRS-2)

Secondary Outcome Measures
NameTimeMethod
Evidence of change in brain functionwithin 30 days after completing the intervention

Confirmed by change in pretest to post-test neuroimaging using MRI

Evidence of improvement in executive functionwithin 14 days after completing the intervention

As confirmed by pretest to post-test changes on the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)

Evidence of improvement in cognitive flexibilitywithin 14 days after completing the intervention

As confirmed by pretest to post-test changes on a Trail Making Test

Evidence of improvement in auditory attentionwith 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Auditory Attention Test (CATA)

Evidence of improvement in visual attentionwith 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Conners Continous Performance Test (CPT-3)

Trial Locations

Locations (1)

Gibson Institute of Cognitive Research

🇺🇸

Colorado Springs, Colorado, United States

Gibson Institute of Cognitive Research
🇺🇸Colorado Springs, Colorado, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.